Factor XII determinations in the presence and absence of phospholipid antibodies

Thrombosis and Haemostasis

Volumn 79, Issue 1, 1998, Pages 87-90

  Gallimore, M J ^a   Jones, D W ^a   Winter, M ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; CHROMOGENIC SUBSTRATE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; HUMAN; IMMUNOCHEMISTRY; IMMUNOELECTROPHORESIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY;

EID: 0031974130     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614225     Document Type: Article

References (21)

1. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot promoting fraction from plasma. J Clin Invest 1955; 34: 602-13.
2. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister H-E. FXII. Blut 1990; 61: 258-66.
3. von Kanel R, Wuillemin WA, Furlan M, Lämmle B. Factor XII clotting activity and antigen levels in patients with thromboembolic disease. Blood Coag Fibrinol 1992; 3: 555-61.
4. Kluft C, Dooijewaard G, Emeis JJ. Role of the contact system in fibrinolysis. Sem Thromb Haemost 1987; 13: 50-68.
5. Levi M, Hack CE, de Boer JP, Brandjes DPM, Büller HR, ten Cate JW. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. J Clin Invest 1991; 88: 1155-60.
6. Winter M, Gallimore MJ, Jones DW. Should factor XII assays be included in thrombophilia screening? Lancet 1995; 1: 52.
7. Halbmayer W-M, Mannhalter C, Feichtinger C, Rubi K, Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 1992; 68: 285-90.
8. Ehrenforth S, Zwinge B, Scharrer I, Bray G. Factor XII deficiency in young people with venous thrombophilia: An analysis of 1554 cases. Blood 1995; 86: 10 (Suppl 1): 879.
9. Jones DW, Gallimore MJ, Winter M. Pseudo FXII deficiency and phospholipid antibodies. Thromb Haemost 1996; 75: 696-7.
10. Halbmeyer WM, Haushofer A, Angerer V, Fischer M. The discrimination of Factor XII deficiency and lupus anticoagulant. Thromb Haemost 1996; 75: 698-9.
11. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ 1983; 287: 1088-91.
12. Jones DW, Gallimore MJ, Winter M. An automated chromogenic peptide substrate assay for factor XII (Hageman factor). Fibrinolysis 1996; 10 (3): 97.
13. Loizou S, McRea JD, Rudge AC, Reynolds R, Boyle C, Harris EN. Measurement of anticardiolipin antibodies in an enzyme linked immunosorbant assay: standardisation and quantitation of results. Clin Exp Immunol 1985; 62: 738-45.
14. McNally T, Mackie IJ, Isenberg DA, Machin SJ. Immunoelectrophoresis and ELISA techniques for assay of plasma β2 glycoprotein-1 and the influence of plasma lipids. Thromb Res 1993; 72: 275-86.
15. Gallimore MJ, Rees WA, Guhrer G, Heller W. A direct chromogenic peptide substrate assay for Hageman factor (FXII). Fibrinolysis 1987; 1: 123-7.
16. Jones DW, Gallimore MJ, Winter M, Grant D, Mackie I, Machin S. The incidence of factor XII deficiency in a population of blood donors. Thromb Haemost 1997; 79 (6): 212.
17. Jaeger U, Kapiotis S, Papinger I, Puchhammer E, Kyrel P, Lechner K. Transient lupus anticoagulant associated with hypoprothrombmaemia and factor XII deficiency following adenovirus infections. Annals Haematol 1993; 67 (2): 95-9.
18. Brookfield C, Malia RG, Cooper SM, Greaves M. Factor XII levels and the lupus anticoagulant. Thromb Haemost 1995; 73 (6): 1441.
19. Schousboe I. β2 glycoprotein-1: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-91.
20. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2 glycoprotein-1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
21. Sugi T, McIntyre JA. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognisable by antiphosphatidyl-ethanolamine antibodies. Thromb Haemost 1996; 76 (3): 354-60.